MIM
GH icon

Macroview Investment Management’s Guardant Health GH Stock Holding History

Macroview Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-96
Closed -$2.2K – 264
2024
Q3 		$2.2K Hold
96
– – ﹤0.01% 464
2024
Q2 		$2.77K Hold
96
– – ﹤0.01% 454
2024
Q1 		$1.98K Sell
96
-264
-73% -$5.66K ﹤0.01% 540
2023
Q4 		$9.74K Buy
360
+104
+41% +$2.73K 0.01% 264
2023
Q3 		$7.59K Buy
+256
New +$9K 0.01% 315

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Macroview Investment Management's GH Position: Q4 2024 in Review

Macroview Investment Management sold out of Guardant Health (GH) in Q4 2024, closing a stake of 96 shares — an estimated $2.2K sold.

Macroview Investment Management first reported a position in GH in Q3 2023 and held it in 5 quarters. The position peaked at $9.74K in Q4 2023. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

  • Macroview Investment Management reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 96 Guardant Health shares in Q4 2024, an estimated $2.2K.
  • Macroview Investment Management first reported a position in Guardant Health in Q3 2023 and held it in 5 quarters.
  • Macroview Investment Management's Guardant Health position peaked at $9.74K in Q4 2023.
  • 298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.